-
Ozempic: Reports of Gastrointestinal Disorder Ileus Added to Drug Label in September 2023
Paralytic Ileus, the Slowing of Food Movement Through Digestive System, is Similar to Intestinal Obstruction (Posted by Tom Lamb at Drug Injury Watch) In September 2023 the Ozempic (semaglutide) drug label was updated to inform…
-
Severe Stomach Conditions in Patients Using Semaglutide Weight Loss Drugs From Novo Nordisk
Ozempic, Rybelsus, and Wegovy Use Might Cause Gastroparesis, Gastric Stasis, or Stomach Paralysis (Posted by Tom Lamb at Drug Injury Watch) Semaglutide is the active ingredient in three Novo Nordisk drugs that are being used…
-
Syfovre Adverse Reaction Cases: Updated Number of Patients With Retinal Vasculitis, Timeline of Events
Additional Information from Apellis and the American Society of Retina Specialists About Ongoing Syfovre Safety Issues (Posted by Tom Lamb at Drug Injury Watch) UPDATE: From this February 28, 2024, Fierce Pharma news report, "Apellis cites…
-
Syfovre Retinal Vasculitis And Severe Intraocular Inflammation Cases Reported By Ophthalmologists
A July 2023 "Dear Doctor" Letter From Apellis Acknowledges This Developing Syfovre Safety Signal Situation (Posted by Tom Lamb at Drug Injury Watch) UPDATE: From this February 28, 2024, Fierce Pharma news report, "Apellis cites current…
